Complex Litigation Corner

What could a professional cycling team, an Indian manufacturer of generic drugs and a Swiss bank have in common? Thanks to whistle-blowers, they are among a growing list of entities recently in the crosshairs of federal prosecutors protecting American consumers and taxpayer interests. By now, we all are familiar with the well-worn Lance Armstrong saga. Against-all-odds-cancer-survivor …